tiprankstipranks
Trending News
More News >

Organogenesis Holdings Approves Key Proposals at Annual Meeting

Story Highlights
  • Organogenesis Holdings re-elected Garrett Lustig and other directors at the 2025 Annual Meeting.
  • Stockholders approved executive compensation, stock issuance, and RSM US LLP’s appointment for 2025.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Organogenesis Holdings Approves Key Proposals at Annual Meeting

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from Organogenesis Holdings ( (ORGO) ).

On June 23, 2025, Organogenesis Holdings held its Annual Meeting of Stockholders where several key proposals were voted on and approved. The meeting included the re-election of Garrett Lustig to the board of directors and the election of other directors to serve until the next annual meeting. Additionally, stockholders approved the compensation for named executive officers and the issuance of over 20% of Class A common stock upon conversion of Series A Convertible Preferred Stock, which may be deemed a change of control under Nasdaq rules. The appointment of RSM US LLP as the independent registered public accounting firm for 2025 was also ratified.

The most recent analyst rating on (ORGO) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Organogenesis Holdings stock, see the ORGO Stock Forecast page.

Spark’s Take on ORGO Stock

According to Spark, TipRanks’ AI Analyst, ORGO is a Neutral.

Organogenesis Holdings’ stock score is primarily affected by its financial performance challenges, including declining revenue and profitability, negative cash flow, and valuation concerns with a negative P/E ratio. Technical analysis suggests bearish momentum, further weighing on the stock. Despite these challenges, reaffirmed guidance and strategic initiatives discussed in the earnings call provide some optimism for potential recovery.

To see Spark’s full report on ORGO stock, click here.

More about Organogenesis Holdings

Average Trading Volume: 1,429,894

Technical Sentiment Signal: Sell

Current Market Cap: $409.7M

See more insights into ORGO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1